RE: Separation Agreement and General ReleaseSeparation Agreement • September 1st, 2022 • Brooklyn ImmunoTherapeutics, Inc. • Pharmaceutical preparations • California
The purpose of this separation agreement (the “Separation Agreement”) is to memorialize the terms and conditions of the separation of your employment with Brooklyn ImmunoTherapeutics, Inc. (the “Company”) and its subsidiaries and affiliates (together with the Company collectively, the “Company Group”), as well as that certain Executive Employment Agreement, dated June 5, 2021, by and between YOU (the terms “YOU” and “YOUR” refers to Kevin D’ Amour) and the Company (the “Employment Agreement”). Capitalized terms used but not defined here in shall have the meanings ascribed thereto in the Employment Agreement.
